Cybin (CYBN.NE) has selected social anxiety disorder (SAD) and generalized anxiety disorder (GAD) as the targets for their CYB004 proprietary psychedelic molecule. Cybin demonstrated their proof of concept for…
Mushrooms
Field Trip Health (FTRP.T) announced that it has completed initial drug metabolism and pharmacokinetic (DMPK) studies for FT-104. Field Trip completed in vivo and in vitro studies. The in…
Core One Labs (COOL.C) announced that their wholly-owned subsidiary Vocan Biotechnologies are in the final stages of completing their provisional patent application for the protection of their proprietary biosynthetic…
When you write about the psychedelics industry, most of the people you speak with are corporate executives and most of what you read comes from PR personnel, so speaking…
Through the last year of the COVID-19 pandemic, healthcare workers have been on the front lines, bearing the brunt of the challenging circumstances. And, in an attempt to repay…
PharmaDrug (BUZZ.C) announced that its Super Smart division has launched a Slim Winkel branded online retail platform in The Netherlands and Europe. The Slim Winkel store will offer functional…
Lobe Sciences (LOBE.C) entered into a production and supply agreement with psychedelics biotech company, HAVN Life Sciences (HAVN.C) today, for their Vitamind line of functional mushrooms, according to a…
Numinus Wellness (NUMI.V) and Optimi Health (OPTI.C) announced they have submitted a pre-clinical trial application to Health Canada. The application was submitted through Impact Clinical Trials Accelerator at the…
At Equity.Guru, engaged as we are in market awareness programs for public companies, we often see competing entities that are more promotional than journalistic, banging out borderline insanity regarding…